S. Sabapathy, C. Neslusan, K. Yoong, A. Teschemaker, P. Johansen, and M. Willis, “COST-EFFECTIVENESS OF CANAGLIFLOZIN VERSUS SITAGLIPTIN WHEN ADDED TO METFORMIN AND SULFONYLUREA IN TYPE 2 DIABETES IN CANADA”, J Popl Ther Clin Pharmacol, vol. 23, no. 2, Nov. 2018, Accessed: Nov. 19, 2024. [Online]. Available: https://mail.jptcp.com/index.php/jptcp/article/view/206